SNIPR Biome
PrivateLast Round
Series B
Aug 7, 2025
Total Funding Raised
$124.87M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SNIPR Biome is a biotechnology company that develops CRISPR-based medicines designed to treat microbial diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SNIPR Biome Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
SNIPR Biome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 7, 2025 | ||||
| Debt | Dec 9, 2024 | ||||
| Grant | Apr 22, 2024 | ||||
| Grant | May 27, 2021 | ||||
| Series A | Mar 11, 2019 | ||||
Seed | Jul 1, 2017 |
SNIPR Biome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Seed, Series A |
| EQT Life Sciences | Series A |
| CARB-X | Grant |
| Lundbeckfonden BioCapital | Series B |
| Gates Foundation | Grant |
| European Investment Bank Group | Debt |
| Cystic Fibrosis Foundation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2025
Developing a phage cocktail to treat Pseudomonas infections.
- Aug 7, 2025
$39.2M raised in Series B funding.
SNIPR Biome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SNIPR Biome's valuation, stock price, and market status.